J. Craig Venter Institute, also known as JCVI, is a privately owned, US-based research institute founded in 1992, employing approximately 200 individuals. The institute specializes in biotechnology research, primarily focusing on genomic research.
On June 22, 2026, the J. Craig Venter Institute (JCVI) published research on how a tiny, abundant ocean alga thrives in the subsurface chlorophyll maximum layer (SCML). This "hidden green zone" below the ocean's surface, which is dimmer than surface waters and shaped by nutrient gradients, serves as an important yet understudied component of the ocean’s biological engine, with chlorophyll indicating photosynthesis. Previously, on June 12, 2026, JCVI recommended that NHS pneumococcal and seasonal flu vaccinations be made available to individuals experiencing homelessness. This initiative aims to offer better protection and well-being through winter for vulnerable groups, while also reducing the spread of flu to protect the wider public.
Similar Companies
Subscribe for full access to J. Craig Venter Institute (JCVI)'s profile
Subscribe for full access to J. Craig Venter Institute (JCVI)'s products in full detail
Subscribe for full access to J. Craig Venter Institute (JCVI)'s revenue in full detail